These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 33364877)

  • 1. The Association between Chronic Use of Renin-Angiotensin-Aldosterone System Blockers and in-Hospital Adverse Events among COVID-19 Patients with Hypertension.
    Cetinkal G; Kocas BB; Ser OS; Kilci H; Yildiz SS; Ozcan SN; Verdi Y; Altinay M; Kilickesmez K
    Sisli Etfal Hastan Tip Bul; 2020; 54(4):399-404. PubMed ID: 33364877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of renin-angiotensin-aldosterone system (RAAS) inhibitors is associated with a lower risk of mortality in hypertensive COVID-19 patients: A systematic review and meta-analysis.
    Wang Y; Chen B; Li Y; Zhang L; Wang Y; Yang S; Xiao X; Qin Q
    J Med Virol; 2021 Mar; 93(3):1370-1377. PubMed ID: 33095513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of renin-angiotensin-aldosterone system inhibition on mortality in critically ill COVID-19 patients with pre-existing hypertension: a prospective cohort study.
    Sato K; White N; Fanning JP; Obonyo N; Yamashita MH; Appadurai V; Ciullo A; May M; Worku ET; Helms L; Ohshimo S; Juzar DA; Suen JY; Bassi GL; Fraser JF; Arora RC;
    BMC Cardiovasc Disord; 2022 Mar; 22(1):123. PubMed ID: 35321649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation Between Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19 Severity.
    Alhaddad MJ; Almulaify MS; Alshabib AA; Alwesaibi AA; Alkhameys MA; Alsenan ZK; Alsheef HJ; Alsaghirat MA; Almomtan MS; Alshakhs MN
    Cureus; 2022 Mar; 14(3):e22903. PubMed ID: 35399441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Association Between COVID-19 Mortality and ICU Admission Rates and Prior History of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use Among Hospitalized COVID-19 Patients With Hypertension in Michigan.
    Elhouderi E; Elsawalhy E; Al-Sudani N; Mahmood I; Sengstock D
    Cureus; 2023 Aug; 15(8):e43980. PubMed ID: 37746496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients with hypertension hospitalized with COVID-19 pneumonia using angiotensinconverting enzyme inhibitors and angiotensin II receptor blockers or other antihypertensives: retrospective analysis of 435 patients.
    Baslilar S; Saylan B
    Ann Saudi Med; 2021; 41(5):268-273. PubMed ID: 34618609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin-converting enzyme inhibitors (ACEI) or angiotensin receptor blockers (ARBs) may be safe for COVID-19 patients.
    Wang W; Zhao X; Wei W; Fan W; Gao K; He S; Zhuang X
    BMC Infect Dis; 2021 Jan; 21(1):114. PubMed ID: 33494713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19.
    Zhang P; Zhu L; Cai J; Lei F; Qin JJ; Xie J; Liu YM; Zhao YC; Huang X; Lin L; Xia M; Chen MM; Cheng X; Zhang X; Guo D; Peng Y; Ji YX; Chen J; She ZG; Wang Y; Xu Q; Tan R; Wang H; Lin J; Luo P; Fu S; Cai H; Ye P; Xiao B; Mao W; Liu L; Yan Y; Liu M; Chen M; Zhang XJ; Wang X; Touyz RM; Xia J; Zhang BH; Huang X; Yuan Y; Loomba R; Liu PP; Li H
    Circ Res; 2020 Jun; 126(12):1671-1681. PubMed ID: 32302265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 In-Hospital Mortality and Use of Renin-Angiotensin System Blockers in Geriatrics Patients.
    Genet B; Vidal JS; Cohen A; Boully C; Beunardeau M; Marine Harlé L; Gonçalves A; Boudali Y; Hernandorena I; Bailly H; Lenoir H; Piccoli M; Chahwakilian A; Kermanach L; de Jong L; Duron E; Girerd X; Hanon O
    J Am Med Dir Assoc; 2020 Nov; 21(11):1539-1545. PubMed ID: 33138935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With COVID-19 Diagnosis and Mortality.
    Fosbøl EL; Butt JH; Østergaard L; Andersson C; Selmer C; Kragholm K; Schou M; Phelps M; Gislason GH; Gerds TA; Torp-Pedersen C; Køber L
    JAMA; 2020 Jul; 324(2):168-177. PubMed ID: 32558877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Renin-Angiotensin-Aldosterone System Inhibitors in Patients with COVID-19: a Systematic Review and Meta-analysis of 28,872 Patients.
    Baral R; White M; Vassiliou VS
    Curr Atheroscler Rep; 2020 Aug; 22(10):61. PubMed ID: 32830286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-Converting Enzyme (ACE) Inhibitors and Angiotensin Receptor Blockers (ARB) Are Protective Against ICU Admission and Mortality for Patients With COVID-19 Disease.
    ElAbd R; AlTarrah D; AlYouha S; Bastaki H; Almazeedi S; Al-Haddad M; Jamal M; AlSabah S
    Front Med (Lausanne); 2021; 8():600385. PubMed ID: 33748156
    [No Abstract]   [Full Text] [Related]  

  • 13. Drugs acting on the renin-angiotensin-aldosterone system (RAAS) and deaths of COVID-19 patients: a systematic review and meta-analysis of observational studies.
    Sharma R; Kumar A; Majeed J; Thakur AK; Aggarwal G
    Egypt Heart J; 2022 Sep; 74(1):64. PubMed ID: 36068392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertension, renin-angiotensin-aldosterone-system-blocking agents, and COVID-19.
    Kang SH; Lee DH; Han KD; Jung JH; Park SH; Dai AM; Wei HG; Yoon CH; Youn TJ; Chae IH; Kim CH
    Clin Hypertens; 2021 Jun; 27(1):11. PubMed ID: 34059140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of RAAS inhibitors on acute hypoxemic respiratory failure and in-hospital mortality in the hypertensive Covid-19 patients.
    Akyüz A; Işık F; Aslan B; Çap M; Kaya İ; Atlı Ö; İnci Ü; Taştan E; Aktan A; Bilge Ö; Okşul M; Aydın E; Karahan Z; Altıntaş DD; Altındağ R; Adıyaman MŞ; Altıntaş B
    Clin Exp Hypertens; 2021 Oct; 43(7):587-596. PubMed ID: 33955313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between renin angiotensin aldosterone system blockers and future osteoporotic fractures in a hypertensive population - A population-based cohort study in Taiwan.
    Kao YT; Huang CY; Fang YA; Liu JC
    Int J Cardiol; 2020 Apr; 305():147-153. PubMed ID: 31955975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Death in Patients Hospitalised with COVID-19: A Retrospective Italian Cohort Study of 43,000 Patients.
    Trifirò G; Massari M; Da Cas R; Menniti Ippolito F; Sultana J; Crisafulli S; Giorgi Rossi P; Marino M; Zorzi M; Bovo E; Leoni O; Ludergnani M; Spila Alegiani S;
    Drug Saf; 2020 Dec; 43(12):1297-1308. PubMed ID: 32852721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Charlson comorbidity index, neutrophil-to-lymphocyte ratio and undertreatment with renin-angiotensin-aldosterone system inhibitors predict in-hospital mortality of hospitalized COVID-19 patients during the omicron dominant period.
    Sonaglioni A; Lombardo M; Albini A; Noonan DM; Re M; Cassandro R; Elia D; Caminati A; Nicolosi GL; Harari S
    Front Immunol; 2022; 13():958418. PubMed ID: 36090992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of renin-angiotensin system inhibitors use on mortality in severe COVID-19 patients with hypertension: a retrospective observational study.
    Zhong Y; Zhao L; Wu G; Hu C; Wu C; Xu M; Dong H; Zhang Q; Wang G; Yu B; Lv J; Wu C; Zhang S; Cao C; Shu L; Pan Y; Liu X; Wu F
    J Int Med Res; 2020 Dec; 48(12):300060520979151. PubMed ID: 33322988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renin-Angiotensin-Aldosterone System Blockers Prior to Hospitalization and Their Association With Clinical Outcomes in Coronavirus Disease 2019 (COVID-19).
    Banwait R; Singh D; Blanco A; Rastogi V; Abusaada K
    Cureus; 2021 Feb; 13(2):e13429. PubMed ID: 33758716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.